![Bin Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bin Zhang
Vorstandsvorsitzender bei Cytovance Biologics, Inc.
Aktive Positionen von Bin Zhang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cytovance Biologics, Inc.
![]() Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Vorstandsvorsitzender | 08.09.2020 | - | |
Präsident | 01.01.2018 | - |
Karriereverlauf von Bin Zhang
Ehemalige bekannte Positionen von Bin Zhang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Comptroller/Controller/Auditor | 15.04.2016 | 29.04.2022 |
Direktor/Vorstandsmitglied | 26.05.2021 | 29.04.2022 | |
Finanzdirektor/CFO | 15.04.2016 | 29.04.2022 |
Statistik
International
China | 2 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 2 |
Comptroller/Controller/Auditor | 1 |
Director of Finance/CFO | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Cytovance Biologics, Inc.
![]() Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |